3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neoplasms
6
Depression
4
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Anxiety Disorders
2
Urologic Diseases
1
Treatment Adherence and Compliance
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sarcoma
1
Radiation Fibrosis Syndrome
1
Pyloric Stenosis, Hypertrophic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Hemorrhage
1
Peripheral Lung Tumor
1
Patient Acceptance of Health Care
1
Obesity
1
Neoplasm Metastasis
1
Interventions
Doxorubicin
15
pembrolizumab
12
Surgical Procedures, Operative
8
Cyclophosphamide
8
Blood Specimen Collection
8
Ifosfamide
7
Gemcitabine
7
Surveys and Questionnaires
6
Nivolumab
6
Trabectedin
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Drug Therapy
5
atezolizumab
4
Temozolomide
4
Specimen Handling
4
Radiation Dose Hypofractionation
4
Biopsy
4
pazopanib
3
liposomal doxorubicin
3
fludarabine
3
cabozantinib
3
anlotinib
3
Radiation
3
Observation
3
Docetaxel
3
Dacarbazine
3
trastuzumab deruxtecan
2
toripalimab
2
selinexor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma
×
Therapeutics
×
Clear all
NCT03099681
2025-11-18
EPISObs
Italian Sarcoma Group
Recruiting
100 enrolled